What was the market valuation of the US anxiety disorder-treatment market in 2024?

The market valuation was $1437.44 Million in 2024. Read More

What is the projected market valuation for the US anxiety disorder-treatment market by 2035?

The projected valuation for 2035 is $2888.57 Million. Read More

What is the expected CAGR for the US anxiety disorder-treatment market during the forecast period 2025 - 2035?

The expected CAGR is 6.55% during the forecast period 2025 - 2035. Read More

Which companies are considered key players in the US anxiety disorder-treatment market?

Key players include Pfizer Inc, Eli Lilly and Company, Johnson & Johnson, and others. Read More

What are the main segments of the US anxiety disorder-treatment market?

Main segments include Medication, Psychotherapy, Support Groups, and Transcranial Magnetic Stimulation. Read More

What was the market size for medication in the US anxiety disorder-treatment market in 2024?

The market size for medication was between $600.0 Million and $1200.0 Million in 2024. Read More

How does the market size for psychotherapy compare to medication in the US anxiety disorder-treatment market?

Psychotherapy had a market size between $400.0 Million and $800.0 Million, which is lower than medication. Read More

What is the market size for adults in the US anxiety disorder-treatment market?

The market size for adults was between $718.72 Million and $1440.285 Million in 2024. Read More

What therapeutic approaches are included in the US anxiety disorder-treatment market?

Therapeutic approaches include Cognitive Behavioral Therapy, Exposure Therapy, and Mindfulness-Based Therapy. Read More

What was the market size for anti-anxiety medications in the US anxiety disorder-treatment market in 2024?

The market size for anti-anxiety medications was between $430.0 Million and $860.0 Million in 2024. Read More

US Anxiety Disorder Treatment Market

ID: MRFR/HC/18035-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

US Anxiety Disorder Treatment Market Research Report: Size, Share, Trend Analysis By Treatment Type (Medication, Psychotherapy, Support Groups, Transcranial Magnetic Stimulation, Lifestyle Changes), By Medication Class (Antidepressants, Anti-anxiety Medications, Beta-Blockers, Antipsychotics), By Patient Demographics (Children, Adolescents, Adults, Elderly) and By Therapeutic Approaches (Cognitive Behavioral Therapy, Exposure Therapy, Mindfulness-Based Therapy, Relaxation Techniques) - Growth Outlook & Industry Forecast 2025 To 2035

US Anxiety Disorder Treatment Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Type (USD Million)
  1. 4.1.1 Medication
  2. 4.1.2 Psychotherapy
  3. 4.1.3 Support Groups
  4. 4.1.4 Transcranial Magnetic Stimulation
  5. 4.1.5 Lifestyle Changes
2. 4.2 Life Sciences, BY Medication Class (USD Million)
  1. 4.2.1 Antidepressants
  2. 4.2.2 Anti-anxiety Medications
  3. 4.2.3 Beta-Blockers
  4. 4.2.4 Antipsychotics
3. 4.3 Life Sciences, BY Patient Demographics (USD Million)
  1. 4.3.1 Children
  2. 4.3.2 Adolescents
  3. 4.3.3 Adults
  4. 4.3.4 Elderly
4. 4.4 Life Sciences, BY Therapeutic Approaches (USD Million)
  1. 4.4.1 Cognitive Behavioral Therapy
  2. 4.4.2 Exposure Therapy
  3. 4.4.3 Mindfulness-Based Therapy
  4. 4.4.4 Relaxation Techniques
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Pfizer Inc (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Eli Lilly and Company (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johnson & Johnson (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 AstraZeneca PLC (GB)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bristol-Myers Squibb Company (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 GlaxoSmithKline PLC (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Sanofi S.A. (FR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Novartis AG (CH)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 AbbVie Inc (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY MEDICATION CLASS
4. 6.4 US MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
5. 6.5 US MARKET ANALYSIS BY THERAPEUTIC APPROACHES
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY MEDICATION CLASS, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY MEDICATION CLASS, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY THERAPEUTIC APPROACHES, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY THERAPEUTIC APPROACHES, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY MEDICATION CLASS, 2025-2035 (USD Million)
  3. 7.2.3 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
  4. 7.2.4 BY THERAPEUTIC APPROACHES, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Life Sciences Market Segmentation

Life Sciences By Type (USD Million, 2025-2035)

Medication
Psychotherapy
Support Groups
Transcranial Magnetic Stimulation
Lifestyle Changes

Life Sciences By Medication Class (USD Million, 2025-2035)

Antidepressants
Anti-anxiety Medications
Beta-Blockers
Antipsychotics

Life Sciences By Patient Demographics (USD Million, 2025-2035)

Children
Adolescents
Adults
Elderly

Life Sciences By Therapeutic Approaches (USD Million, 2025-2035)

Cognitive Behavioral Therapy
Exposure Therapy
Mindfulness-Based Therapy
Relaxation Techniques

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”